OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.900
-0.090 (-3.01%)
Nov 4, 2024, 4:00 PM EST - Market closed
OncoCyte Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -36.14 | -27.78 | -72.9 | -64.1 | -29.93 | -22.43 | Upgrade
|
| Depreciation & Amortization | 1.41 | 1.68 | 5.22 | 4.21 | 0.39 | 0.35 | Upgrade
|
| Other Amortization | - | - | 0.01 | 0.06 | 0.1 | 0.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.28 | 1.28 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.69 | 6.76 | 44.55 | - | 0.42 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.16 | 0.06 | 0.47 | -0.23 | -0.3 | 0.05 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 0.27 | 1.55 | 0.28 | Upgrade
|
| Stock-Based Compensation | 2.12 | 2.89 | 10.04 | 6.84 | 5.07 | 3.23 | Upgrade
|
| Other Operating Activities | 13.03 | -5.76 | -31.02 | 16.86 | -5.26 | 0.26 | Upgrade
|
| Change in Accounts Receivable | 0.21 | 0.11 | -0.58 | -1.23 | -0.18 | - | Upgrade
|
| Change in Accounts Payable | -0.82 | -4.76 | 0.3 | -1.35 | 0.85 | 0.74 | Upgrade
|
| Change in Other Net Operating Assets | 0.06 | 0.68 | -1.66 | 2.73 | 1.32 | -2.3 | Upgrade
|
| Operating Cash Flow | -18 | -23.33 | -45.57 | -35.94 | -25.98 | -19.72 | Upgrade
|
| Capital Expenditures | -0.5 | -0.28 | -4.34 | -2.25 | -1.23 | -0.92 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.23 | 0.35 | - | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | -11.71 | -6.51 | - | Upgrade
|
| Investment in Securities | 0.37 | 0.37 | - | - | -4 | -11.25 | Upgrade
|
| Other Investing Activities | - | -1.37 | - | - | -0.01 | -0.25 | Upgrade
|
| Investing Cash Flow | 0.1 | -0.93 | -4.34 | -13.96 | -11.75 | -12.42 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 1.14 | 3 | Upgrade
|
| Long-Term Debt Repaid | - | -0.12 | -1.43 | -1.53 | -0.45 | -1.64 | Upgrade
|
| Net Debt Issued (Repaid) | -0.09 | -0.12 | -1.43 | -1.53 | 0.7 | 1.36 | Upgrade
|
| Issuance of Common Stock | 15.81 | 13.85 | 32.84 | 83.2 | 22.25 | 49.79 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -0.24 | -0.01 | - | Upgrade
|
| Other Financing Activities | -0.54 | -0.43 | -0.48 | -3.07 | -0.13 | -3.29 | Upgrade
|
| Financing Cash Flow | 9.79 | 12.19 | 35.81 | 78.36 | 22.8 | 47.87 | Upgrade
|
| Net Cash Flow | -8.11 | -12.07 | -14.1 | 28.46 | -14.93 | 15.74 | Upgrade
|
| Free Cash Flow | -18.5 | -23.61 | -49.91 | -38.19 | -27.21 | -20.63 | Upgrade
|
| Free Cash Flow Margin | -1808.11% | -1570.59% | -5209.60% | -1737.40% | -2237.42% | - | Upgrade
|
| Free Cash Flow Per Share | -1.96 | -3.09 | -9.01 | -8.59 | -8.31 | -8.04 | Upgrade
|
| Cash Interest Paid | - | - | 0.02 | 0.11 | 0.21 | 0.17 | Upgrade
|
| Levered Free Cash Flow | -5.22 | -6.9 | -11.74 | -6.71 | -13.95 | -12.76 | Upgrade
|
| Unlevered Free Cash Flow | -5.19 | -6.86 | -11.7 | -6.64 | -13.89 | -12.82 | Upgrade
|
| Change in Net Working Capital | -1.61 | 0.92 | 0.52 | -1.92 | -2.2 | 1.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.